The Second Receptor for C5a, C5aR2, Is Detrimental to Mice during Systemic Infection with Listeria monocytogenes

Stacey L Mueller-Ortiz1, Pooja Shivshankar1, Rick A Wetsel2,3

  • 1Brown Foundation Institute of Molecular Medicine, Research Center for Immunology and Autoimmune Diseases, University of Texas Health Science Center at Houston, Houston, TX 77030; and.

Insights

The complement receptor C5aR2 plays a crucial role in Listeria monocytogenes infection. Deleting C5aR2 enhances host immunity, leading to reduced bacterial load and improved survival by boosting early IL-12 and IFN-γ production.

Area of Science:

  • Immunology
  • Microbiology
  • Infectious Diseases

Background:

  • Listeria monocytogenes infection poses a significant mortality risk.
  • Previous studies identified anti-inflammatory and prosurvival roles for C5aR1 and C3aR in systemic L. monocytogenes infection.

Purpose of the Study:

  • To investigate the role of the anaphylatoxin receptor C5aR2 in the host immune response to systemic L. monocytogenes infection.

Main Methods:

  • Comparative analysis of C5aR2 knockout (C5aR2-/-) and wild-type (C5aR2+/+) mice infected with L. monocytogenes.
  • Assessment of bacterial burdens, organ damage, immune cell survival, and cytokine profiles (G-CSF, IL-6, MCP-1, IFN-γ, IL-12p70).
  • In vitro infection assays with purified splenocytes to evaluate cytokine production in an NF-κB-dependent manner.

Main Results:

  • C5aR2-/- mice exhibited significantly lower bacterial burdens in the spleen and liver.
  • Reduced liver damage and improved CD4+ and CD8+ T cell survival were observed in C5aR2-/- mice.
  • C5aR2-/- mice produced less G-CSF, IL-6, and MCP-1, but demonstrated an enhanced capacity for IL-12 and IFN-γ production in vitro, indicating a more robust early innate immune response.

Conclusions:

  • C5aR2 negatively regulates the early innate immune response to systemic L. monocytogenes infection.
  • The absence of C5aR2 leads to increased IL-12 and IFN-γ production, conferring protection against infection.
  • Targeting C5aR2 may represent a therapeutic strategy to enhance host defense against L. monocytogenes.

Related Concept Videos